§ Funding Round
Series B funding round for OncoResponse raising $40M in September 2018
Series B funding round for OncoResponse raising $40M in September 2018
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Thompson Hutton (Thompson Hutton) | — | — |
| Organization | — | |
| Organization | — | |
Canaan Partners | — | — |
Helsinn Investment Fund | — | — |
HT Family Office | — | — |
| Organization | — | |
| Organization | — | |
john mckearnLEAD | Angel | john mckearn |
William Marsh Rice University | — | — |
This company has completed 8 funding rounds. Current round is highlighted.
Total Raised
$214.5M
Top Valuation
-
OncoResponse raised $40M in a Series B round.
The round was announced on 09/01/18.
The round was led by john mckearn.
